[ad_1]
A year after the death of Aretha Franklin, a singer estate-financed fund was established to help research the rare form of pancreatic cancer that afflicted the Queen of Souls.
Franklin died in August 2018 after a battle with a neuroendocrine tumor (NET) on the pancreas, a form of cancer that is causing only 7% of pancreatic cancer cases. Similarly, Apple CEO Steve Jobs has died as a result of a rare disease relapse in 2011.
On the first anniversary of Franklin's death, the Detroit Women's Informal Network and the singer's estate took the opportunity to donate to the Foundation for Neuroendocrine Tumor Research (NETRF) based in Boston, which created the Aretha Franklin Fund for Neuroendocrine Cancer Research, the Detroit Free Press reports.
"The Aretha Franklin family is honored to partner with the NETRF to help raise funds for education and research on this devastating disease that takes our loved ones too soon," Sabrina Owens said in a statement. the niece of Aretha Franklin and representative of the family.
"We encourage his friends, fans, and fans to consider contributing to this cause until we can eradicate NETs." We believe that it is possible. "
"A lot of the work we fund is in basic science in the lab. We are trying to understand why these tumors develop and spread, "said Elyse Gellerman, Executive Director of NETRF. Detroit Free Press.
"We do not know all the answers about it. Researchers are trying to understand these tumors at the cellular level and – with some of the available treatments – why some patients respond and others do not. "
Gellerman added that the fund would raise awareness of the rare disease. "I know that the community of neuroendocrine tumors is frustrated when the cause of Aretha Franklin's death has not been properly reported."
Franklin was diagnosed with the disease for the first time in 2010 and would have spread rumors about his health for years. Dr. Philip A. Philip, Franklin Oncologist, told the Free Press"The time spent by people with this disease is measured in years, not fractions of years or months, as is the case for most patients (who most often have adenocarcinoma of the pancreas. "
[ad_2]
Source link